Fully automated chip-based nanoelectrospray ionization-mass spectrometry as an effective tool for rapid and high-throughput screening of 5α-reductase inhibitors.
Level 5 - mechanism / opinion, no new human data
In vitro bench and analytical assay development without human subjects
PubMed 32008083 · doi:10.1007/s00216-020-02408-y
What was done
Researchers developed an automated, chip-based nanoelectrospray ionization-mass spectrometry (nano-ESI-MS) direct infusion assay to screen for 5α-reductase inhibitors. The method was evaluated using curcumin as a candidate inhibitor, and performance was compared against conventional high-performance liquid chromatography-mass spectrometry (HPLC-MS).
What was found
The abstract reports no numerical values (such as IC50 values, percentage inhibition rates, throughput speed, or limits of detection). It qualitatively notes that curcumin exhibited notable 5α-reductase inhibitory activity and that the chip-based nano-ESI-MS results were consistent with HPLC-MS.
Why it matters
Direct-infusion mass spectrometry on a microfluidic chip simplifies sample preparation and accelerates throughput for early-stage screening of potential 5α-reductase inhibitors.
Limits
The study is entirely in vitro and methodological. The abstract reports no quantitative performance metrics, sample sizes, or replication data, and it evaluates only a single test compound (curcumin) without in vivo biological testing.
Cited by
- supports Curcumin lowers dihydrotestosterone (DHT).